Alvaro
Lassaletta Atienza
Consultor Médico
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (10)
2024
-
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer
Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2351-2359
-
Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience
Frontiers in Pediatrics, Vol. 12
2023
-
Role of urine culture in paediatric patients with cancer with fever and neutropenia: A prospective observational study
Archives of Disease in Childhood, Vol. 108, Núm. 12, pp. 982-986
2022
2020
-
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15
-
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
Frontiers in Pediatrics, Vol. 8
2019
-
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1763-1770
2013
-
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse
American Journal of Hematology, Vol. 88, Núm. 5, pp. 359-364
2012
-
Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement
Clinical and Translational Oncology, Vol. 14, Núm. 4, pp. 280-286
2011
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica